Among these factors, the GnRH-agonist protocol, AFC, AMH, number of oocytes retrieved, number of high-quality cleavage embryos and number of embryos transferred were determined as independent protective factors for clinical pregnancy in endometriosis patients. This evidence concerns the gene AMH and endometriosis.